Company Research Report: Aetion, Inc.

Company Overview

• Name: Aetion, Inc.

• Mission: Aetion's mission is to power critical decisions in healthcare with data science-driven technology.

• Founded: 2013

• Founders: Faculty members from Harvard Medical School with experience in epidemiology and health outcomes research.

• Key People:

• Jeremy Rassen, Sc.D. (Co-founder & CEO)

• Kevin Riley (President)

• Nicolle Gatto, Ph.D., M.P.H. (Chief Science Officer)

• Sebastian Schneeweiss, M.D., Sc.D. (Co-Founder and Senior Advisor)

• Wendy Turenne (Chief Data Officer)

• Ken Watson (Chief Technology Officer)

• Others listed in leadership and board positions.

• Headquarters: 5 Penn Plaza, 7th Floor, New York, NY, 10001

• Science & Technology Offices: Boston, MA, Ottawa, ON, and Barcelona, Spain

• Number of Employees: No information is available.

• Revenue: No information is available.

• Company Known For: Aetion is known for providing real-world evidence (RWE) solutions and creating a platform — the Aetion Evidence Platform® — which facilitates the transformation of real-world data into valid, transparent, and replicable real-world evidence to aid critical decision-making in healthcare.

Products

1. Aetion Evidence Platform® (AEP)

• Description: AEP is a robust analytics engine designed for the management and analysis of real-world data (RWD) to produce real-world evidence (RWE).

• Key Features:

• Supports longitudinal data from diverse sources.

• Integrates analytic logic and compliance with latest standards.

• Provides intuitive, visual-first analytics with built-in APIs.

2. Aetion® Discover

• Description: An application for exploratory analysis, allowing quick insights into population data and outcomes.

• Key Features:

• Enables visualization and description of populations and outcomes.

• Supports exploratory research questions.

• Accepts various data formats.

3. Aetion® Substantiate

• Description: A tool for implementing high-impact, decision-grade studies with no-code workflows.

• Key Features:

• Provides workflows for study designs and causal studies.

• Ensures robust, transparent, and replicable results.

• Allows use of best practices like SPIFD and START-RWE.

4. Aetion® Generate

• Description: An application for generating synthetic health data that enhances data utility while preserving privacy.

• Key Features:

• Protects sensitive data while ensuring high security and utility.

• Assists in the detection and resolution of re-identification risks.

• Provides cloud-based or on-premise solutions for data privacy.

Recent Developments

• Recent Products Launched:

• Aetion® Generate: Utilizes generative AI to create statistically similar datasets maintaining privacy.

• New Features:

• Enhancement of analytical capabilities through partners like Evio to address pharmaceutical needs.

• Partnerships:

• Partnership with FDA and other regulatory bodies to explore the potential of RWE in regulatory science.

• Collaboration with xCures to expand the partnership for richer datasets.

• Joint ventures with organizations like Evio for real-world data-based pharmacy solutions.

News & Events

• Aetion has participated in strategic alliances and initiatives such as the RCT-DUPLICATE and CARE Initiative to advance the use of RWE in regulatory contexts.

• Active in hosting events such as oncology RWE workshops for advancing regulatory-grade evidence.

• Recent leadership changes include the appointment of Jeremy Rassen as CEO and Kevin Riley discussing the future of RWE with Nasdaq.

Additional Information

• Aetion has strong ties with notable investors such as New Enterprise Associates, Warburg Pincus, and Flare Capital Partners.

• Aetion continues striving to establish industry standards for real-world data and real-world evidence, making notable advancements in the field of healthcare analytics.

For further details and inquiries, visit their official website: [Aetion](https://aetion.com).